Mous J - Search Results

1

Reduced sensitivity to saquinavir: an update on genotyping from phase I/II trials.

Jacobsen H, Haenggi M, Ott M, Duncan IB, Andreoni M, Vella S, Mous J. Jacobsen H, et al. Among authors: mous j. Antiviral Res. 1996 Jan;29(1):95-7. doi: 10.1016/0166-3542(95)00927-2. Antiviral Res. 1996. PMID: 8721556

2

Characterization of human immunodeficiency virus type 1 mutants with decreased sensitivity to proteinase inhibitor Ro 31-8959.

Jacobsen H, Yasargil K, Winslow DL, Craig JC, Kröhn A, Duncan IB, Mous J. Jacobsen H, et al. Among authors: mous j. Virology. 1995 Jan 10;206(1):527-34. doi: 10.1016/s0042-6822(95)80069-7. Virology. 1995. PMID: 7831807 Free article.

3

In vivo resistance to a human immunodeficiency virus type 1 proteinase inhibitor: mutations, kinetics, and frequencies.

Jacobsen H, Hänggi M, Ott M, Duncan IB, Owen S, Andreoni M, Vella S, Mous J. Jacobsen H, et al. Among authors: mous j. J Infect Dis. 1996 Jun;173(6):1379-87. doi: 10.1093/infdis/173.6.1379. J Infect Dis. 1996. PMID: 8648209

4

Progression of early steps of human immunodeficiency virus type 1 replication in the presence of an inhibitor of viral protease.

Jacobsen H, Ahlborn-Laake L, Gugel R, Mous J. Jacobsen H, et al. Among authors: mous j. J Virol. 1992 Aug;66(8):5087-91. doi: 10.1128/JVI.66.8.5087-5091.1992. J Virol. 1992. PMID: 1378515 Free PMC article.

5

Conserved residues Pro-109 and Asp-116 are required for interaction of the human immunodeficiency virus type 1 integrase protein with its viral DNA substrate.

Drelich M, Haenggi M, Mous J. Drelich M, et al. Among authors: mous j. J Virol. 1993 Aug;67(8):5041-4. doi: 10.1128/JVI.67.8.5041-5044.1993. J Virol. 1993. PMID: 8392628 Free PMC article.

6

Emergence of resistant variants of HIV in vivo during monotherapy with the proteinase inhibitor saquinavir.

Ives KJ, Jacobsen H, Galpin SA, Garaev MM, Dorrell L, Mous J, Bragman K, Weber JN. Ives KJ, et al. Among authors: mous j. J Antimicrob Chemother. 1997 Jun;39(6):771-9. doi: 10.1093/jac/39.6.771. J Antimicrob Chemother. 1997. PMID: 9222047

7

Identification of an amino acid substitution involved in the reduction of sensitivity of HIV-1 to an inhibitor of viral proteinase.

Turriziani O, Antonelli G, Jacobsen H, Mous J, Riva E, Pistello M, Dianzani F. Turriziani O, et al. Among authors: mous j. Acta Virol. 1994 Oct;38(5):297-8. Acta Virol. 1994. PMID: 7726006

8

Kinetic and structural analyses of hepatitis C virus polyprotein processing.

Bartenschlager R, Ahlborn-Laake L, Mous J, Jacobsen H. Bartenschlager R, et al. Among authors: mous j. J Virol. 1994 Aug;68(8):5045-55. doi: 10.1128/JVI.68.8.5045-5055.1994. J Virol. 1994. PMID: 8035505 Free PMC article.

9

Nonstructural protein 3 of the hepatitis C virus encodes a serine-type proteinase required for cleavage at the NS3/4 and NS4/5 junctions.

Bartenschlager R, Ahlborn-Laake L, Mous J, Jacobsen H. Bartenschlager R, et al. Among authors: mous j. J Virol. 1993 Jul;67(7):3835-44. doi: 10.1128/JVI.67.7.3835-3844.1993. J Virol. 1993. PMID: 8389908 Free PMC article.

10

Tumor necrosis factor receptor p55 mediates induction of HIV type 1 expression in chronically infected U1 cells.

Edfjäll C, Jacobsen H, Lötscher H, Mous J. Edfjäll C, et al. Among authors: mous j. AIDS Res Hum Retroviruses. 1996 Feb 10;12(3):199-204. doi: 10.1089/aid.1996.12.199. AIDS Res Hum Retroviruses. 1996. PMID: 8835197

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

69 results

Search Page

Filters